Contraceptive Pills Market to Grow with a CAGR of 6.76% through 2030

Rising consumer consciousness regarding family planning and the increasing population is expected to drive the Global Contraceptive Pills Market growth in the forecast period, 2026-2030.

According to TechSci Research report, “Contraceptive Pills Market – Global Industry Size, Share, Trends, Competition Forecast & Opportunities, 2030”, the Global Contraceptive Pills Market stood at USD 34.21 billion in 2024 and is anticipated to grow with a CAGR of 6.76% in the forecast period through 2030. The escalating number of unintended births is a major catalyst behind the growing demand for contraceptive drugs, consequently fueling the expansion of the global contraceptive drugs market. An important driver that is propelling the growth of this market is the increased emphasis placed by prominent industry players and healthcare organizations on raising awareness through public programs, aimed at broadening the accessibility to a range of contraceptive drug options. Moreover, during the projected period, the growth of the global contraceptive drugs market is expected to be fueled by the approval, development, and commercialization of innovative and long-lasting techniques.

Several factors are driving market growth, including the increasing incidence of sexually transmitted diseases, a rising rate of unintended pregnancies, and government initiatives. The global prevalence of unwanted pregnancies is a major concern, with approximately half of all pregnancies worldwide being unintended. According to the United Nations Population Fund, around 121 million unintended pregnancies occur each year, with over 60% ending in abortion. Alarmingly, an estimated 45% of abortions are unsafe, contributing to maternal fatalities and jeopardizing the achievement of Sustainable Development Goals. Moreover, a study published in BMC Pregnancy and Childbirth 2021 revealed that approximately 85 million women worldwide are affected by unintended pregnancies, with India alone accounting for a significant portion. In particular, Uttar Pradesh, India's most populous state, has a disproportionately high unwanted fertility rate compared to the rest of the country. Consequently, the increasing number of unintended pregnancies is expected to drive the demand for contraceptive drugs and devices, thereby fueling market growth.

Furthermore, the rising prevalence of sexually transmitted diseases among the population is poised to contribute to market expansion. For example, a report by the Centers for Disease Control and Prevention highlighted a significant number of Syphilis cases, including the highly infectious primary and secondary stages. Additionally, data from the World Health Organization indicated a staggering number of new infections of sexually transmitted diseases, such as chlamydia, gonorrhea, Syphilis, and trichomoniasis. This mounting burden emphasizes the need for contraception to prevent the transmission of diseases, thus stimulating market growth.

Moreover, governments worldwide have recognized the importance of curbing unplanned pregnancies and have implemented various campaigns to educate and prevent such occurrences. The promotion and support of voluntary family planning and reproductive health initiatives by organizations like the United States Agency for International Development exemplify this commitment. Additionally, government-led programs, such as the National Chlamydia Screening Program in the United Kingdom, aim to reduce the risk of untreated chlamydia infection through timely testing, treatment, and re-testing. These government initiatives play a crucial role in promoting the use of contraceptive methods to avoid unnecessary births and abortions. While these factors contribute to market growth, challenges persist, such as the high cost of devices and treatment, as well as potential side effects associated with contraceptive drugs and devices. These factors may hinder market growth over the forecast period.

Browse over XX market data Figures spread through XX Pages and an in-depth TOC on "Global Contraceptive Pills Market.”

The Global Contraceptive Pills Market is segmented into pill type, category, sales channel, regional distribution, and company.

Based on pill type, the combination pill category is experiencing the fastest growth in the global contraceptive pills market. These pills, which contain both estrogen and progestin, are widely used due to their high effectiveness in preventing pregnancy and their additional health benefits, such as regulating menstrual cycles, reducing acne, and alleviating symptoms of premenstrual syndrome (PMS). One of the key reasons behind the growing popularity of combination pills is their versatility and suitability for a wide range of users. Healthcare professionals often prefer prescribing these pills because they offer more predictable cycle control and have a longer track record of safe use. Moreover, combination pills are available in different formulations—such as monophasic, biphasic, and triphasic—allowing them to be tailored to individual hormonal needs, which enhances user satisfaction and compliance. Consumer awareness, improvements in women’s healthcare services, and the increasing accessibility of family planning methods are also contributing to the rising demand for combination pills. In many countries, combination oral contraceptives are included in public health initiatives and insurance coverage, making them more affordable and widely adopted. As a result of these combined factors, the combination pill segment is outpacing other types, including progestin-only pills, in terms of market growth and acceptance across diverse regions and demographics.

Based on Region, Asia-Pacific is experiencing the fastest growth in the global contraceptive pills market. This growth is being driven by several key factors, including increasing awareness about reproductive health, expanding access to contraceptive options, and supportive government initiatives aimed at population control and family planning. Countries in this region, particularly India, China, Indonesia, and Vietnam, are investing in public health campaigns that promote the use of contraceptive pills as a safe and effective method of birth control. In addition to public initiatives, there is a growing shift in societal attitudes towards women's health and autonomy. As more women in Asia-Pacific enter the workforce and pursue higher education, the demand for reliable and convenient contraceptive methods like oral pills has increased. Improvements in healthcare infrastructure and broader access to medical advice have also made it easier for women to obtain and use contraceptive pills confidently.

Major companies operating in Global Contraceptive Pills Market are:

• Bayer AG
• Amneal Pharmaceuticals LLC
• Teva Pharmaceuticals Industries Ltd.
• Abbvie Inc. (Allergan PLC)
• Pfizer Inc.
• Johnson & Johnson
• Aurobindo Pharma Limited
• Organon International (Merck & Co. Inc.)
• Sanofi SA
• Mayne Pharma Group Ltd

Download Free Sample Report

Customers can also request for 10% free customization on this report.

“The global contraceptive drugs market is driven by factors such as increasing consumer consciousness about family planning, rising population, and growing instances of unintended pregnancies. Healthcare practitioners are increasingly favoring modern contraceptive methods due to their multiple benefits, leading to better clinical outcomes and optimal safety. The market is also supported by frequent approvals of novel medications by regulatory bodies. Innovations like gelatin capsules and non-hormonal vaginal gels are further propelling market growth. Continuous R&D activities and initiatives by NGOs and health agencies to educate consumers about contraception techniques, women's health, and sexual wellness are positively impacting the market.,” said Mr. Karan Chechi, Research Director of TechSci Research, a research-based management consulting firm.

“Contraceptive Pills Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Pill Type (Progestin Pills & Combination Pills), By Category (Generic & Branded), By Sales Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), By Region and Competition, 2020-2030F”, has evaluated the future growth potential of Global Contraceptive Pills Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global Contraceptive Pills Market.